| Primary |
| Breast Cancer |
41.5% |
| Product Used For Unknown Indication |
26.3% |
| Hypertension |
4.6% |
| Breast Cancer Female |
3.7% |
| Back Pain |
2.8% |
| Bone Metastases |
1.5% |
| Invasive Ductal Breast Carcinoma |
1.5% |
| Liver Metastases |
1.5% |
| Lung Metastases |
1.5% |
| Lymph Node Metastases |
1.5% |
| Malignant Melanoma Stage Iv |
1.5% |
| Metastasis |
1.5% |
| Type 2 Diabetes Mellitus |
1.5% |
| Abdominal Pain |
1.2% |
| Abdominal Pain Upper |
1.2% |
| Anaemia |
1.2% |
| Chemotherapy |
1.2% |
| Chest Pain |
1.2% |
| Diabetes Mellitus |
1.2% |
| Invasive Lobular Breast Carcinoma |
1.2% |
|
| Macular Degeneration |
8.2% |
| Vaginal Haemorrhage |
8.2% |
| Uterine Cancer |
6.8% |
| Muscle Spasms |
5.5% |
| Pain In Extremity |
5.5% |
| Thrombocytopenia |
5.5% |
| Vaginal Discharge |
5.5% |
| Weight Increased |
5.5% |
| Death |
4.1% |
| Maculopathy |
4.1% |
| Neuropathy Peripheral |
4.1% |
| Ovarian Cyst |
4.1% |
| Pancreatitis |
4.1% |
| Pruritus Genital |
4.1% |
| Pulmonary Embolism |
4.1% |
| Sensation Of Heaviness |
4.1% |
| Thrombosis |
4.1% |
| Uterine Polyp |
4.1% |
| Visual Acuity Reduced |
4.1% |
| Vulvovaginal Pruritus |
4.1% |
|
| Secondary |
| Breast Cancer |
55.8% |
| Product Used For Unknown Indication |
16.0% |
| Breast Cancer Metastatic |
4.4% |
| Invasive Ductal Breast Carcinoma |
3.5% |
| Breast Cancer Female |
2.9% |
| Metastases To Liver |
2.1% |
| Hypertension |
1.5% |
| Neoplasm |
1.4% |
| Bone Metastases |
1.3% |
| Liver Metastases |
1.3% |
| Lung Metastases |
1.3% |
| Lymph Node Metastases |
1.3% |
| Malignant Melanoma Stage Iv |
1.3% |
| Prophylaxis |
1.1% |
| Pain |
1.1% |
| Depression |
1.0% |
| Breast Cancer Male |
0.8% |
| Malignant Melanoma |
0.8% |
| Chemotherapy |
0.6% |
| Immunosuppressant Drug Therapy |
0.6% |
|
| Metastasis |
22.4% |
| Neoplasm Progression |
10.7% |
| Malignant Neoplasm Progression |
10.3% |
| Weight Increased |
7.9% |
| Disease Progression |
5.6% |
| Malignant Respiratory Tract Neoplasm |
5.1% |
| Weight Decreased |
4.7% |
| Acute Myeloid Leukaemia |
3.7% |
| Oesophageal Carcinoma |
3.7% |
| Endometrial Cancer |
2.8% |
| Metastases To Reproductive Organ |
2.8% |
| Rash |
2.8% |
| Death |
2.3% |
| Off Label Use |
2.3% |
| Osteonecrosis |
2.3% |
| Pulmonary Embolism |
2.3% |
| Skin Cancer |
2.3% |
| Drug Intolerance |
1.9% |
| Lip Swelling |
1.9% |
| Neutropenic Sepsis |
1.9% |
|
| Concomitant |
| Breast Cancer |
31.0% |
| Product Used For Unknown Indication |
19.3% |
| Breast Cancer Metastatic |
10.3% |
| Metastases To Bone |
8.5% |
| Drug Use For Unknown Indication |
3.8% |
| Depression |
3.7% |
| Pain |
3.4% |
| Hypertension |
3.3% |
| Osteoporosis |
2.6% |
| Rheumatoid Arthritis |
1.8% |
| Prophylaxis |
1.6% |
| Breast Cancer Female |
1.5% |
| Anxiety |
1.3% |
| Neoplasm Malignant |
1.3% |
| Atrial Fibrillation |
1.3% |
| Blood Cholesterol Increased |
1.3% |
| Diabetes Mellitus |
1.1% |
| Hypothyroidism |
1.1% |
| Fibromyalgia |
0.9% |
| Invasive Ductal Breast Carcinoma |
0.9% |
|
| Weight Decreased |
17.3% |
| Vomiting |
12.4% |
| Rash |
5.2% |
| Tooth Extraction |
5.2% |
| Weight Increased |
5.2% |
| Drug Ineffective |
4.8% |
| Death |
4.5% |
| Wound |
4.5% |
| X-ray Abnormal |
4.5% |
| Nausea |
3.9% |
| Osteonecrosis Of Jaw |
3.9% |
| Pain |
3.6% |
| Pain In Extremity |
3.6% |
| Breast Cancer |
3.3% |
| White Blood Cell Count Decreased |
3.3% |
| Disease Progression |
3.0% |
| Osteonecrosis |
3.0% |
| Pleural Effusion |
3.0% |
| Tumour Marker Increased |
2.7% |
| Vision Blurred |
2.7% |
|
| Interacting |
| Breast Cancer |
57.1% |
| Metastasis |
17.9% |
| Metastatic Malignant Melanoma |
4.8% |
| Abdominal Pain |
1.2% |
| Abdominal Pain Upper |
1.2% |
| Anaemia |
1.2% |
| Blood Cholesterol Increased |
1.2% |
| Blood Triglycerides Increased |
1.2% |
| Brain Oedema |
1.2% |
| Breast Cancer In Situ |
1.2% |
| Breast Cancer Stage Iv |
1.2% |
| Chest Pain |
1.2% |
| Convulsion |
1.2% |
| Depression |
1.2% |
| Headache |
1.2% |
| Hyperparathyroidism Secondary |
1.2% |
| Lower Respiratory Tract Infection |
1.2% |
| Major Depression |
1.2% |
| Metastases To Bone |
1.2% |
| Nausea |
1.2% |
|
| Osteonecrosis |
29.4% |
| Drug Interaction |
11.8% |
| Weight Decreased |
11.8% |
| Drug Level Decreased |
5.9% |
| Emotional Distress |
5.9% |
| Hypersomnia |
5.9% |
| Malignant Neoplasm Progression |
5.9% |
| Neoplasm Progression |
5.9% |
| Thrombocytopenia |
5.9% |
| Vomiting |
5.9% |
| White Blood Cell Count Decreased |
5.9% |
|
